Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
My Portfolio
Latest News about Lannett Co/ Inc/
Recent news which mentions Lannett Co/ Inc/
Lannett bankruptcy; CVS turns away from acquisitions: The National Observer May 4, 2023
May 04, 2023
Tags
Super Micro Computer Inc/
Lannett Co/ Inc/
Wizards of the Coast LLC
From
Business Journals
Lab notes: Adaptimmune to reduce workforce; NRx completes $11M debt financing
November 11, 2022
Tickers
INNO
Tags
Stephen Willard
Insurance
Trevena Inc/
From
Business Journals
Lab Notes: Tela Bio secures $50M loan deal; Senzo's home Covid-19 test achieves 100% accuracy
June 03, 2022
Tickers
INNO
Tags
Immunocore Holdings plc
Tela Bio Inc/
Jeremy Stackawitz
From
Business Journals
Lab Notes: Gene therapy milestone celebrated; CHOP pioneer Dr. Katherine High honored
May 13, 2022
Tickers
INNO
Tags
Pharmaceuticals
Emily Whitehead
Katherine High
From
Business Journals
Lab Notes: Jazz agrees to multimillion-dollar drug sale; Lannett takes 'major step' with biosimilar
April 01, 2022
Tickers
INNO
Tags
The Children's Hospital Of Philadelphia
Roundup
Lannett Co Inc
From
Business Journals
Lab Notes: Chimeron's Covid-19 vaccine candidate shows promise; Lannett gets 2nd NYSE delisting notice
March 25, 2022
Tickers
INNO
Tags
Tim Crew
Health Care
Recro Pharma Inc/
From
Business Journals
Lab Notes: LIMR awarded research grant; Virpax posts positive study results for pain treatment
January 21, 2022
Tickers
INNO
Tags
Melvin Reichman
Inno
George Prendergast
From
Business Journals
Lab Notes: Lannett files FDA application for new drug; Virpax to start clinical trial for knee pain drug candidate
December 23, 2021
Tickers
INNO
Tags
Pharmaceuticals
Anthony Mack
Tim Crew
From
Business Journals
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.